Souhaitez-vous accéder aux communiqués récents ?

STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...

Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pump Market Industry Trends and Global Forecasts to 2035 - Distribution by Type of Pump (Tethered Pumps and Patch Pumps), Degree of Automation,...

Inflammasome-driven inflammation in obesity results in severely damaged pancreatic islets, leading to islet cell loss and metabolic dysfunction.

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: Understanding the Type 2 Diabetes Patient Experience" report has been added to ResearchAndMarkets.com's...

Kailera today announced its launch as a clinical-stage biopharmaceutical company advancing next-generation therapies for obesity and related conditions.

Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...

Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes - April 2024" report has been added to ResearchAndMarkets.com's offering. This report provides an...

Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Global Self-Monitoring Blood Glucose Device Market Report by Product, Application, End-User, Regions and Company Analysis 2024-2032" report has been...

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pump Market Report by Types, Diseases, Accessories, End-user Countries and Company Analysis 2024-2032" report has been added to ...

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Connected Diabetes Care: Innovations and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research provides...